Cargando…
Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation
Cardiac glycosides could increase intracellular Ca(2+) ion by inhibiting the Na(+)/K(+)ATPase to induce apoptosis in many tumor cells. However, narrow therapeutic index, poor tumor selectivity and severe cardiovascular toxicity hinder their applications in cancer treatment. To improve the safety pro...
Autores principales: | Zhang, Hui-Yun, Xu, Wen-Qian, Zheng, Yuan-yuan, Omari-Siaw, Emmanuel, Zhu, Yuan, Cao, Xia, Tong, Shan-Shan, Yu, Jiang-nan, Xu, Xi-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349917/ https://www.ncbi.nlm.nih.gov/pubmed/27861145 http://dx.doi.org/10.18632/oncotarget.13389 |
Ejemplares similares
-
Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy
por: Zhang, Huiyun, et al.
Publicado: (2017) -
Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo
por: Liu, Tao, et al.
Publicado: (2016) -
Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome
por: Zhang, Huiyun, et al.
Publicado: (2022) -
Periplocymarin Alleviates Doxorubicin-Induced Heart Failure and Excessive Accumulation of Ceramides
por: Yun, Weijing, et al.
Publicado: (2021) -
Periplocymarin Plays an Efficacious Cardiotonic Role via Promoting Calcium Influx
por: Yun, Weijing, et al.
Publicado: (2020)